Predict your next investment

HEALTHCARE | Biotechnology
novogene.com

See what CB Insights has to offer

Founded Year

2011

Stage

IPO | IPO

Total Raised

$72.67M

Date of IPO

4/13/2021

About Novogene

Novogene (688315.SH) is a provider of genomic services and solutions.

Novogene Headquarter Location

Building 301, Zone A10 Jiuxianqiao North Road, Chaoyang District

Beijing, Beijing,

China

+86 010-82837801

Latest Novogene News

Global Plant Genetic Engineering Market - Forecast to 2026

Sep 17, 2021

Agilent Technologies, Eurofins Scientific Se, Illumina, Inc., Keygene N.V., Neogen Corporation, Novogene Corporation Ltd., Nrgene Ltd., Oxford Nanopore Technologies Ltd., Qiagen N.V, and Sgs -Traitgenetics Gmbh, among others are major identified companies in the market. September 17, 2021 10:21 ET Mumbai, INDIA Brooklyn, New York, Sept. 17, 2021 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Plant Genetic Engineering Market will grow with a CAGR value of around 6 percent over the forecast period [2021 to 2026]. Plant Genetic Engineering is a future-focused method to advance the agriculture industry. Benefits such as building crop resistance against pests, disease, and the capability to withstand severe weather conditions have promoted the need for plant genetic engineering. Expansion in greenhouse farms, vertical farms, and indoor farms to grow seasonal crops throughout the year will also support the industry growth. However, regulations pertaining to long-term health threats caused by these crops may limit the market expansion. Yield improvement dominated the trait segment The yield improvement trait is among the most preferred quality which is kept in consideration while opting for crop modification. The increased demand and supply gap has encouraged big farm providers to adopt the plant engineering method to uplift the production and quality of the crop. Fruits & Vegetables holds the highest potential The fruits & vegetable applications hold the maximum potential to lead the industry growth. High success rate, increased requirement of seasonal fruits & vegetables throughout the year will induce growth in this segment. Increased penetration of indoor vertical farmings to grow some crops throughout the year due to their significance in daily food will promote technology adoption. North America led the regional revenue share The North American plant genetic engineering market share led the overall demand in 2020 and accounted for approximately 40% of the revenue share in the same year. Favorable government regulations about modified crop plantations have positively influenced regional growth. Also, the presence of numerous companies investing in crop modification will support the expansion in the coming years. Technical advancement and improvised product development will be the prime strategy Major identified providers in the industry are Eurofins Scientific Se, Agilent Technologies, Illumina, Inc., Neogen Corporation, Keygene N.V., Novogene Corporation Ltd., Oxford Nanopore Technologies Ltd., Qiagen N.V, Sgs -Traitgenetics Gmbh, and Nrgene Ltd, among others. The global plant genetic engineering company revenue share is concentrated due to presence of few companies having license to offer solutions on an international platform. Technological advancements to improve the offering and achieve maximum production are the prime focus of leading companies. Browse the Report @  https://www.globalmarketestimates.com/market-report/plant-genetic-engineering-market-3536 Yield improvement Artificial Selection Cereals & Grains

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Novogene

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Novogene is included in 2 Expert Collections, including Biopharmaceuticals.

B

Biopharmaceuticals

5,880 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

O

Omics

1,029 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Novogene Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Novogene Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.